| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/15/2010 | US20100093628 Methods of treatment using wisp polypeptides |
| 04/15/2010 | US20100093627 Albumin fusion proteins |
| 04/15/2010 | US20100093626 Peptide and small molecule agonists of epha and their uses in disease |
| 04/15/2010 | US20100093625 Smoothened polypeptides and methods of use |
| 04/15/2010 | US20100093624 Peptide therapeutics that bind vegf and methods of use thereof |
| 04/15/2010 | US20100093623 Compositions and methods for modulating nod-like receptor activity and uses thereof |
| 04/15/2010 | US20100093622 method of producing native components, such as growth factors or extracellular matrix proteins, through cell culturing of tissue samples for tissue repair |
| 04/15/2010 | US20100093621 Scgb3a2 as a growth factor and anti-apoptotic agent |
| 04/15/2010 | US20100093620 Tyrosine-rich conopeptides |
| 04/15/2010 | US20100093618 Polypeptide capable of inhibiting hiv-1 transcription and replication and uses thereof |
| 04/15/2010 | US20100093617 Use |
| 04/15/2010 | US20100093616 Combination of EGF/GHRP-6 for Neurogeneration of Central Nervous System Following Autoimmune Damage |
| 04/15/2010 | US20100093615 Antibacterial compounds and processes for its production |
| 04/15/2010 | US20100093614 Novel Composition for Tumor Growth Control |
| 04/15/2010 | US20100093613 Methods for identifying agents and their use for the prevention or stabilization of fibrosis |
| 04/15/2010 | US20100093612 Integrin targeted cyclopeptide ligands, their preparation and use |
| 04/15/2010 | US20100093611 Compounds and methods for treating or preventing autoimmune diseases |
| 04/15/2010 | US20100093610 Romidepsin-based treatments for cancer |
| 04/15/2010 | US20100093609 Prodrugs of triciribine and triciribine phosphate |
| 04/15/2010 | US20100093607 Synergistic therapeutic use of prothrombin complex concentrates with fviii concentrates |
| 04/15/2010 | US20100093606 MRSA Bactericidal Topical Gel |
| 04/15/2010 | US20100093605 Peptides, derivatives and analogs thereof, and methods of using same |
| 04/15/2010 | US20100093604 Gpr43 and modulators thereof for the treatment of metabolic-related disorders |
| 04/15/2010 | US20100093603 Use of organic compounds |
| 04/15/2010 | US20100093602 Methods and compositions for modulating adhesion and migration of cadherin expressing cells |
| 04/15/2010 | US20100093601 Compositions and methods to protect cells by blocking entry of pathogen proteins |
| 04/15/2010 | US20100093600 Regulation of neurotransmitters sequestration and release through manipulation of the vesicular functions |
| 04/15/2010 | US20100093056 Antibodies that bind dkk-related proteins |
| 04/15/2010 | US20100092568 Drug microparticles |
| 04/15/2010 | US20100092566 Highly concentrated drug particles, formulations, suspensions and uses thereof |
| 04/15/2010 | US20100092561 Methods and compositions using substance p to promote wound healing |
| 04/15/2010 | US20100092560 Reduced coenzyme q10-containing particulate composition and method for producing the same |
| 04/15/2010 | US20100092559 Boldine compounds for promoting bone growth |
| 04/15/2010 | US20100092558 Method for Producing a Product Having a Polymer Matrix, Implants Made Thereof and Use Thereof |
| 04/15/2010 | US20100092545 Polyethylene-oxide based films and drug delivery systems made therefrom |
| 04/15/2010 | US20100092543 Dimpled adhering troche for use on teeth or orthodontic braces |
| 04/15/2010 | US20100092539 Fluorinated GHRH Antagonists |
| 04/15/2010 | US20100092538 Nucleic Acids Encoding Spider Glue Proteins and Methods of Use Thereof |
| 04/15/2010 | US20100092536 Implantable sensors and implantable pumps and anti-scarring agents |
| 04/15/2010 | US20100092526 Nanoemulsion therapeutic compositions and methods of using the same |
| 04/15/2010 | US20100092525 Medical device |
| 04/15/2010 | US20100092523 Molecules and methods for treatment and detection of cancer |
| 04/15/2010 | US20100092508 Molecular Antigen Arrays |
| 04/15/2010 | US20100092504 Combined human papillomavirus vlp/gene delivery system and use thereof as a vaccine for prophylaxis and immunotherapy of infectious diseases and tumors |
| 04/15/2010 | US20100092500 Novel immunogenic lipopeptides comprising t-helper and b-cell epitopes |
| 04/15/2010 | US20100092497 Methods of immune or haematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer |
| 04/15/2010 | US20100092493 Modulation of Complement System Activation for Treatment of Bleeding-Related Inflammation |
| 04/15/2010 | US20100092492 Vascular endothelial cell growth factor antagonists |
| 04/15/2010 | US20100092486 Modulation of myeloid differentation primary response gene 88 (myd88) expression by antisense oligonucleotides |
| 04/15/2010 | US20100092481 Human cytomegalovirus neutralising antibodies and use thereof |
| 04/15/2010 | US20100092477 Methods and compositions for treating prostate cancer |
| 04/15/2010 | US20100092471 Porphyromonas Gingivalis Polypeptides Useful in the Prevention of Periodontal Disease |
| 04/15/2010 | US20100092469 Antagonists of a non-selective cation channel in neural cells |
| 04/15/2010 | US20100092468 Method for predicting therapeutic responsiveness to tnf-alpha blocking agents |
| 04/15/2010 | US20100092467 Prevention of tissue ischemia, related methods and compositions |
| 04/15/2010 | US20100092463 Method for treating or preventing osteoporosis by reducing follicle stimulating hormone to cyclic physiological levels in a mammalian subject |
| 04/15/2010 | US20100092462 Methods for Suppressing Toll-Like Receptor Activity |
| 04/15/2010 | US20100092454 novel use of antidepressant compounds and related compositions |
| 04/15/2010 | US20100092453 Method of producing porous microparticles |
| 04/15/2010 | US20100092452 Replenishment and Enrichment of Ocular Surface Lubrication |
| 04/15/2010 | US20100092451 Combination Enzyme Therapy for Digestion of Dietary Gluten |
| 04/15/2010 | US20100092450 Use of Hyaluronidase for the Prevention or Treatment of Arterial Hypertension or Cardiac Insufficiency |
| 04/15/2010 | US20100092449 Treatment of Pompe's Disease |
| 04/15/2010 | US20100092448 Local control of inflammation |
| 04/15/2010 | US20100092447 Methods and compositions for the treatment of symptoms of prion diseases |
| 04/15/2010 | US20100092443 Novel combinations of nitrogenated heterocyclic antibacterial compounds with other antibacterial compounds and the use of same as drugs |
| 04/15/2010 | US20100092434 Thrombopoietic activity of tyrosyl-trna synthetase polypeptides |
| 04/15/2010 | US20100092427 Pyridinone Diketo Acids: Inhibitors of HIV Replication in Combination Therapy |
| 04/15/2010 | US20100092426 2-substituted benzimidazoles |
| 04/15/2010 | US20100092425 Nicotine Immunonanotherapeutics |
| 04/15/2010 | US20100092424 Method of diagnosis and treatment of tumors using high intensity focused ultrasound |
| 04/15/2010 | US20100092423 Pharmaceutical composition comprising an anti-cd6 monoclonal antibody used in the diagnosis and treatment of rheumatoid arthritis |
| 04/15/2010 | US20100092409 that target cytokines; greater activity; produced at greater yields; second protease inhibitory loop of BBPI scaffold is replaced with a binding peptide: VEGF binding peptide, fibroblast growth factor-5 (FGF) binding peptide, transforming growth factor beta (TGF) binding peptide, or TNF binding protein |
| 04/15/2010 | US20100092386 System for delivering therapeutic agents into living cells and cells nuclei |
| 04/15/2010 | CA2740107A1 Compounds for treatment of alzheimer's disease |
| 04/15/2010 | CA2740079A1 Methods of making concentrated fibrinogen- and platelet-containing compositions |
| 04/15/2010 | CA2740046A1 Detection of granulosa-cell tumors |
| 04/15/2010 | CA2739842A1 Antimicrobial peptides and methods of use |
| 04/15/2010 | CA2739796A1 Compositions and methods for detection of antibodies specific for anaplasma phagocytophilum (aph) and anaplasma platys (apl) |
| 04/15/2010 | CA2739715A1 Treating or preventing gout |
| 04/15/2010 | CA2739679A1 Modulation of the activity and differentiation of cells expressing the osteoclast-associated receptor |
| 04/15/2010 | CA2739670A1 Oncostatin m as an enhancer of the immunostimulatory activity of human epithelial cells |
| 04/15/2010 | CA2739615A1 Fgf21 mutants and uses thereof |
| 04/15/2010 | CA2739403A1 Dosage forms that facilitate rapid activation of zymogen |
| 04/15/2010 | CA2739021A1 Cgrp receptor antagonists |
| 04/15/2010 | CA2738983A1 Chemical modulators of pro-apoptotic bax and bcl-2 polypeptides |
| 04/15/2010 | CA2737924A1 Methods of treating inflammation |
| 04/15/2010 | CA2735153A1 High caloric enteral formulations |
| 04/14/2010 | EP2174958A1 Antibodies derived from anti ed-b l19 and targeting tumor vasculature |
| 04/14/2010 | EP2174957A1 Monoclonal antibodies binding to avian influenza virus subtype h5 haemagglutinin and uses thereof |
| 04/14/2010 | EP2174955A1 Ifnar2 muteins, their production and use |
| 04/14/2010 | EP2174954A1 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof |
| 04/14/2010 | EP2174949A2 Leucine-based motif and clostridial neurotoxins |
| 04/14/2010 | EP2174946A1 Methods for chemically synthesizing immunoglobulin chimeric proteins |
| 04/14/2010 | EP2174945A1 Antisense modulation of apolipoprotein B expression |
| 04/14/2010 | EP2174674A1 Methods and compositions for healing and repair of articular cartilage |
| 04/14/2010 | EP2174668A2 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 04/14/2010 | EP2174663A1 Stabilized aqueous compositions comprising tissue factor pathway inhibitor (TFPI) or tissue factor pathway inhibitor variant |
| 04/14/2010 | EP2174662A2 Methods for treating muscle injuries |
| 04/14/2010 | EP2174661A1 Agent for improving dysfunction due to neuropathy and rho kinase activation inhibitor |